Combining blood-based biomarkers to predict risk for Alzheimer’s disease dementia

被引：0
作者：
Suzanne E. Schindler
Randall J. Bateman
机构：
[1] Washington University School of Medicine,Department of Neurology
[2] Washington University School of Medicine,Knight Alzheimer’s Disease Research Center
[3] Washington University School of Medicine,Hope Center for Neurological Disorders
来源：
Nature Aging | 2021年 / 1卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Accurate blood tests for Alzheimer’s disease (AD) are critical tools that have the potential to revolutionize dementia research, clinical trials and clinical care. Models combining blood-based biomarkers that represent multiple aspects of AD brain pathology with key individual level factors may improve prediction of AD dementia.
引用
收藏
页码：26 / 28
页数：2
相关论文
共 23 条
[1]  
Nakamura A(2018)undefined Nature 554 249-254
[2]  
Ovod V(2017)undefined Alzheimers. Dement. 13 841-849
[3]  
Schindler SE(2019)undefined Neurology 93 e1647-e1659
[4]  
Palmqvist S(2020)undefined JAMA 324 772-781
[5]  
Mielke MM(2018)undefined Alzheimers. Dement. 14 989-997
[6]  
Barthelemy NR(2020)undefined J. Exp. Med. 217 e20200861-386
[7]  
Horie K(2020)undefined Nat. Med. 26 379-433
[8]  
Sato C(2020)undefined Lancet Neurol. 19 422-283
[9]  
Bateman RJ(2019)undefined Nat. Med. 25 277-799
[10]  
Janelidze S(2019)undefined JAMA Neurol. 76 791-378
123